Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-08-09 | Amended | $5,847,848 | $1,875,733 | Debt Only | 06b | SEC link |
| 2023-08-10 | Amended | $3,972,115 | $1,199,500 | Debt Only | 06b | SEC link |
| 2021-12-28 | New | $2,772,615 | $2,772,615 | Debt Only | 06b | SEC link |
| 2019-10-02 | New | $3,967,692 | $3,967,692 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| David S. Barlow | Director, Executive |
| Brant Binder | Director, Executive |
| Alan Cross | Director |
| Paul Murphy | Director |
| Bryan Roberts | Director |
| Jerry F. Rosenbaum | Director |
| Jeff Troderman | Executive |
| William Wagner | Executive |
| Daniel Weiss Pick | Director |